Specifically, compared with patients not treated with anti-TNFα, the hdPS-adjusted HR for incident tinnitus among those treated with anti-TNFα was 1.15 (0.92, 1.44) (Figure 1). The gene discussed is TNF; the disease is Tinnitus.